Promacta (eltrombopag) is an oral medicine that increases the number of platelets in the blood. Individuals with a low platelet count can be at significant risk of bleeding or death. Low platelet count is also associated with a large number of diseases, allowing Promacta the opportunity to address a wide range of indications.
|Novartis||ITP, HepC, Severe Aplastic Anemia, Oncology||4.7-9.4%|
Kyprolis® (carfilzomib) for Injection is a Proteosome inhibitor indicated for the treatment of patients with multiple myeloma.
Captisol-enabled IV formulation of voriconazole
|Alvogen||Infectious Disease||Material sales only|
DUAVEE (conjugated estrogens/bazedoxifene) is a progesterone-free treatment for moderate-to-severe vasomotor symptoms (hot flashes) associated with menopause and aids in the prevention of postmenopausal osteoporosis.
Viviant/Conbriza™ (bazedoxifene) is a synthetic drug that was specifically designed to reduce the risk of osteoporotic fractures, while at the same time protecting breast and uterine tissue.
NEXTERONE (amiodarone HCl) Premixed Injection is indicated for initiation of treatment and prophylaxis for frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to the therapy.
|Merck||Infectious Disease||Material sales only|